GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

However, typically, type 2 diabetes is treated with medication plus lifestyle modifications. The following article includes ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

More than 36 million Americans have type 2 diabetes, a condition primarily attributed to the body's cells not responding to ...

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...

The results of this comparative effectiveness research study suggest that sodium-glucose cotransporter-2 inhibitors  and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a ...

Now, an analysis of studies has found that newer medications for type 2 diabetes may help reduce the risk of complications, particularly cardiovascular disease, in some people with type 2 diabetes.

Now, an analysis of studies has found that newer medications for type 2 diabetes may help reduce the risk of complications, particularly cardiovascular disease, in some people with type 2 diabetes.